logo
logo
Sign in

Contraceptive Pills Market to Reach $20.55 Billion by 2026

avatar
Avani Sable
Contraceptive Pills Market to Reach $20.55 Billion by 2026

The global contraceptive pills market size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period. High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market. Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs. The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas. To counter this, governments in many developing and underdeveloped countries are taking efforts to make these modern day medications more accessible and affordable to the rural populace. This will effectively accelerate the oral contraceptives market growth during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-pills-market-101802

Top Players Identified in the Contraceptive Pills Market Report by Fortune Business Insights:

  • Janssen Pharmaceutical Company
  • Piramal Enterprises
  • Allergan, plc
  • Mylan N.V.
  • Pfizer, Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries
  • HLL Lifecare Limited
  • Merck & Co., Inc.

Increasing Popularity of Advanced Contraceptives to Propel the Market in North America

North America is slated to dominate the contraceptive pills market share, since the region generated USD 4.09 billion in revenue in 2018. The primary reason for this is the rising uptake of short-acting reversible contraceptives in the U.S. and patient-friendly reimbursement policies for oral birth-control pills. Europe will emerge as the second leading region in this market, led by France which has the highest birth rate in the region. Better reimbursement policies will also bode well for the market in Europe. Asia-Pacific will record the fastest growth owing to rising number of awareness drives conducted by the government and NGOs. In Latin America, the Middle East, and Africa, increasing presence of big pharmaceutical companies and growing literacy rates will drive the market in these regions.  

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contraceptive-pills-market-101802

Exciting Opportunities Await Local and Regional Players in the Market

While big companies such as Bayer AG are benefiting owing to their well-established presence, smaller players operating at the local and regional level are also slowly gaining ground in this market. This is a result of launching of innovative products by these players along with certain capacity restrictions hounding the large players.

TOC:

  1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

  1. Key Insights

4.1 Fertility Statistics (2018)

4.2 Regulatory scenario for key countries

4.3 Recent industry developments such as mergers & acquisitions

4.4 Key Industry Trends

4.5 Government policies & their impact on contraceptives industry

4.6 New Product Launches

  1. Global Contraceptive Pills Market Analysis, Insights and Forecast, 2015-2026

5.1. Key Findings / Summary

5.2. Market Analysis, Insights and Forecast – By Type

5.2.1 Combined Contraceptives (E+P)

5.2.2 Progestin-only Pills

5.3. Market Analysis, Insights and Forecast – By Distribution Channel

5.3.1 Hospital Pharmacy

TOC Continued...

collect
0
avatar
Avani Sable
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more